Physician profile
Richard E Gray
NPI 1851352710
$2,020.80
in general payments reported to CMS, 2019-2025
13 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,620 · 2021: $17.53 · 2022: $80.75 · 2023: $185 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $302.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $1,407.72 | 2019 | |
| Pacira Therapeutics, INC. | $144.39 | 2019 | |
| Stryker Corporation | $93.91 | 2023 | Mako |
| Polynovo North America LLC | $91.33 | 2023 | |
| Amgen INC. | $43.02 | 2025 | Evenity, Prolia |
| Kci USA, INC. | $38.54 | 2019 | |
| Zimvie INC. | $35.59 | 2022 | |
| Pfizer INC. | $34.58 | 2025 | |
| Merck Sharp & Dohme LLC | $33.08 | 2021-2025 | Bridion |
| Zimmer Biomet Holdings, INC. | $29.70 | 2019 | |
| Baxter Healthcare | $23.78 | 2025 | Perclot |
| Davol INC. | $23.76 | 2022 | |
| Avanos Medical | $21.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.